Pages that link to "Q33469649"
Jump to navigation
Jump to search
The following pages link to Safety and tolerability of duloxetine in the treatment of patients with fibromyalgia: pooled analysis of data from five clinical trials (Q33469649):
Displaying 16 items.
- Effect of duloxetine in patients with fibromyalgia: tiredness subgroups (Q34152987) (← links)
- Duloxetine for the treatment of fibromyalgia (Q34663934) (← links)
- Pharmacotherapy for Fibromyalgia (Q35092347) (← links)
- A randomized, double-blind, placebo-controlled phase III trial of duloxetine in Japanese fibromyalgia patients (Q35986975) (← links)
- Duloxetine: a review of its safety and efficacy in the management of fibromyalgia syndrome (Q36866408) (← links)
- Randomized, Double-blind, Placebo-controlled Phase III Trial of Duloxetine Monotherapy in Japanese Patients With Chronic Low Back Pain (Q37420136) (← links)
- Psychotropic drugs and liver disease: A critical review of pharmacokinetics and liver toxicity (Q37625519) (← links)
- The Role of Antipsychotics in the Management of Fibromyalgia (Q37980516) (← links)
- Management of fibromyalgia in older adults (Q38250183) (← links)
- A systematic review of the efficacy of venlafaxine for the treatment of fibromyalgia (Q38258054) (← links)
- A Randomized, Double-Blind, Placebo-Controlled Phase III Trial of Duloxetine Monotherapy in Japanese Patients with Chronic Low Back Pain (Q39739858) (← links)
- Pharmacological treatment of fibromyalgia syndrome: new developments (Q43210411) (← links)
- Single-agent duloxetine ingestions (Q43446891) (← links)
- An open-label, long-term, phase III extension trial of duloxetine in Japanese patients with fibromyalgia (Q51741053) (← links)
- Efficacy and safety of duloxetine versus placebo in adolescents with juvenile fibromyalgia: results from a randomized controlled trial. (Q64950375) (← links)
- Wikidata:WikiProject Chronic Pain Syndrome/fibromyalgia/As a main topic (← links | edit)